(Q46844433)

25 December 2017

title

Assessment and treatment of suicide risk in schizophrenia (English)

1 reference

25 December 2017

0 references

0 references

1 reference

1

1 reference

25 December 2017

Marco Innamorati

series ordinal

3

1 reference

25 December 2017

Roberto Tatarelli

series ordinal

4

1 reference

25 December 2017

David Lester

series ordinal

2

object named as

David Lester

1 reference

25 December 2017

5

Paolo Girardi

1 reference

25 December 2017

publication date

1 January 2008

1 reference

25 December 2017

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

published in

1 reference

25 December 2017

volume

8

1 reference

25 December 2017

issue

1

1 reference

25 December 2017

page(s)

51-74

1 reference

25 December 2017

Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The Lifetime Risk of Suicide in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Sex differences in completed suicide by schizophrenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide risk in schizophrenia: learning from the past to change the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Premature deaths in schizophrenia and affective disorders. An analysis of survival curves and variables affecting the shortened survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

A Systematic Review of Mortality in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Causes of the excess mortality of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Mortality in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide and violent death among patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide attempts amongst elderly schizophrenia patients: a 10-year case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Mortality among patients with schizophrenia and reduced psychiatric hospital care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Mortality and causes of death in first admitted schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Mortality and causes of death in schizophrenia in Stockholm county, Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide and the unique prevalence pattern of schizophrenia in mainland China: a retrospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide in schizophrenia: findings from a national clinical survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Schizophrenia and suicide: systematic review of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

A clinical study of schizophrenic suicides. 42 cases in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Circumstances of suicide among individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Antecedents of suicide in people with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Risk factors of suicide among schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Schizophrenia and suicide: a 10-year review of Kentucky medical examiner cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Where schizophrenic patients commit suicide: a review of suicide among inpatients and former inpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide after discharge from psychiatric inpatient care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide within 12 months of contact with mental health services: national clinical survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Risk factors for suicide in patients with schizophrenia: nested case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide rates in psychiatric in-patients: an application of record linkage to mental health research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Risk factors for suicide in the immediate post-discharge period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Early detection of the first episode of schizophrenia and suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide and awareness of illness in schizophrenia: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Early insight predicts depression and attempted suicide after 4 years in first-episode schizophrenia and schizophreniform disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The occurrence and characteristics of suicidal preoccupation and acts in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide among schizophrenics: a comparison of attempters and completed suicides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide attempts in schizophrenia and affective disorders with relation to some specific demographical and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The InterSePT scale for suicidal thinking reliability and validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Effect of religion on suicide attempts in outpatients with schizophrenia or schizo-affective disorders compared with inpatients with non-psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide and suicide attempts in adolescent-onset psychotic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Atypical antipsychotics and metabolic dysregulation: evaluating the risk/benefit equation and improving the standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

A meta-analysis of the efficacy of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Increased suicide attempt rate among patients interrupting use of atypical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

How Stigma Interferes With Mental Health Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Toward a new prevention of suicide in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

What's atypical about atypical antipsychotic drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

A critical review of akathisia, and its possible association with suicidal behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicidal risk during treatment with clozapine: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Mortality in current and former users of clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

21 January 2018

Clozapine and suicide

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicidality in schizophrenia: a review of the evidence for risk factors and treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Managing antipsychotic-induced acute and chronic akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Quetiapine is effective against anxiety and depressive symptoms in long-term treatment of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Differential effect of quetiapine on depressive symptoms in patients with partially responsive schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Effects of quetiapine on cognitive functions in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Impact of atypical antipsychotics on quality of life in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Impact of atypical antipsychotics on quality of life, self-report of symptom severity, and demand of services in chronically psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Psychopharmacologic treatment of pathologic aggression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Lithium Treatment Reduces Suicide Risk in Recurrent Major Depressive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Non-neuroleptic approaches to treating negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Antidepressants as add-on treatment to antipsychotics for people with schizophrenia and pronounced negative symptoms: a systematic review of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Obsessive and compulsive symptoms in schizophrenia: a randomized controlled trial with fluvoxamine and neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The role of selegiline in the treatment of negative symptoms associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Clinically significant interactions of psychotropic agents with antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

An analysis of the effect of funding source in randomized clinical trials of second generation antipsychotics for the treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Efficacy of ECT in depression: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The combined use of electroconvulsive therapy and antipsychotics in patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Sandro Morselli: schizophrenic solitude, suicide, and psychotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

A randomized controlled trial of postcrisis suicide prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Suicide schema in schizophrenia: the effect of emotional reactivity, negative symptoms and schema elaboration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Cognitive behavioral therapy reduces suicidal ideation in schizophrenia: results from a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Treatment Adherence Associated With Conventional and Atypical Antipsychotics in a Large State Medicaid Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

The stable patient with schizophrenia--from antipsychotic effectiveness to adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Emergency staff reactions to suicidal and self-harming patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Social support and recovery in people with serious mental illnesses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Assessment of suicidal intention: The Scale for Suicide Ideation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.8.1.51

21 January 2018

Identifiers

DOI

10.1586/14737175.8.1.51

1 reference

25 December 2017

1 reference

25 December 2017